Patent ductus arteriosus treatment trends and associated morbidities in neonates

Abstract To evaluate national epidemiologic data on infants treated for patent ductus arteriosus (PDA) in Korea and analyze outcomes associated with different PDA treatments. We retrospectively evaluated data on 12,336 patients diagnosed with PDA (International Classification of Diseases-10 code: Q2...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joonsik Park, So J Yoon, Jungho Han, In G Song, Joohee Lim, Jeong E Shin, Ho S Eun, Kook I Park, Min S Park, Soon M Lee
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6629daada3944a669ac48160fff98a8b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6629daada3944a669ac48160fff98a8b
record_format dspace
spelling oai:doaj.org-article:6629daada3944a669ac48160fff98a8b2021-12-02T15:45:16ZPatent ductus arteriosus treatment trends and associated morbidities in neonates10.1038/s41598-021-89868-z2045-2322https://doaj.org/article/6629daada3944a669ac48160fff98a8b2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89868-zhttps://doaj.org/toc/2045-2322Abstract To evaluate national epidemiologic data on infants treated for patent ductus arteriosus (PDA) in Korea and analyze outcomes associated with different PDA treatments. We retrospectively evaluated data on 12,336 patients diagnosed with PDA (International Classification of Diseases-10 code: Q250) between 2015 and 2018 from the Health Insurance Review and Assessment database. Among them, 1623 patients underwent surgical ligation (code: O1671). We used birth certificate data from Statistics Korea to estimate the prevalence, diagnosis, and treatment of PDA. The prevalence of infants with PDA was 81 infants per 10,000 live births and 45.2% in very low birth weight (VLBW) infants, which increased from 2015 to 2018. PDA ligation was performed in 2571 infants and 22% VLBW infants. Medical treatment was administered to 4202 infants, which decreased significantly, especially in VLBW infants (62% to 53%). The proportion of treatment was as follows: conservative treatment (53.1%), intravenous ibuprofen (24.4%), surgery (20.4%), and oral ibuprofen (10.7%); that among 4854 VLBW infants was as follows: intravenous ibuprofen (46.3%), conservative treatment (33.2%), surgery (22.2%), and oral ibuprofen (14.2%). Surgical treatment had a significantly higher risk (odds ratio 1.36) of mortality than conservative treatment. Surgical and/or medical treatments were associated with a higher risk of morbidity. Recently, increased use of conservative management of PDA has contributed to improved neonatal outcomes in VLBW infants. Select patients may still benefit from surgical ligation following careful consideration.Joonsik ParkSo J YoonJungho HanIn G SongJoohee LimJeong E ShinHo S EunKook I ParkMin S ParkSoon M LeeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Joonsik Park
So J Yoon
Jungho Han
In G Song
Joohee Lim
Jeong E Shin
Ho S Eun
Kook I Park
Min S Park
Soon M Lee
Patent ductus arteriosus treatment trends and associated morbidities in neonates
description Abstract To evaluate national epidemiologic data on infants treated for patent ductus arteriosus (PDA) in Korea and analyze outcomes associated with different PDA treatments. We retrospectively evaluated data on 12,336 patients diagnosed with PDA (International Classification of Diseases-10 code: Q250) between 2015 and 2018 from the Health Insurance Review and Assessment database. Among them, 1623 patients underwent surgical ligation (code: O1671). We used birth certificate data from Statistics Korea to estimate the prevalence, diagnosis, and treatment of PDA. The prevalence of infants with PDA was 81 infants per 10,000 live births and 45.2% in very low birth weight (VLBW) infants, which increased from 2015 to 2018. PDA ligation was performed in 2571 infants and 22% VLBW infants. Medical treatment was administered to 4202 infants, which decreased significantly, especially in VLBW infants (62% to 53%). The proportion of treatment was as follows: conservative treatment (53.1%), intravenous ibuprofen (24.4%), surgery (20.4%), and oral ibuprofen (10.7%); that among 4854 VLBW infants was as follows: intravenous ibuprofen (46.3%), conservative treatment (33.2%), surgery (22.2%), and oral ibuprofen (14.2%). Surgical treatment had a significantly higher risk (odds ratio 1.36) of mortality than conservative treatment. Surgical and/or medical treatments were associated with a higher risk of morbidity. Recently, increased use of conservative management of PDA has contributed to improved neonatal outcomes in VLBW infants. Select patients may still benefit from surgical ligation following careful consideration.
format article
author Joonsik Park
So J Yoon
Jungho Han
In G Song
Joohee Lim
Jeong E Shin
Ho S Eun
Kook I Park
Min S Park
Soon M Lee
author_facet Joonsik Park
So J Yoon
Jungho Han
In G Song
Joohee Lim
Jeong E Shin
Ho S Eun
Kook I Park
Min S Park
Soon M Lee
author_sort Joonsik Park
title Patent ductus arteriosus treatment trends and associated morbidities in neonates
title_short Patent ductus arteriosus treatment trends and associated morbidities in neonates
title_full Patent ductus arteriosus treatment trends and associated morbidities in neonates
title_fullStr Patent ductus arteriosus treatment trends and associated morbidities in neonates
title_full_unstemmed Patent ductus arteriosus treatment trends and associated morbidities in neonates
title_sort patent ductus arteriosus treatment trends and associated morbidities in neonates
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6629daada3944a669ac48160fff98a8b
work_keys_str_mv AT joonsikpark patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT sojyoon patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT junghohan patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT ingsong patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT jooheelim patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT jeongeshin patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT hoseun patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT kookipark patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT minspark patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
AT soonmlee patentductusarteriosustreatmenttrendsandassociatedmorbiditiesinneonates
_version_ 1718385755041038336